| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/28/2005 | WO2005035545A3 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 07/28/2005 | WO2005033309A3 Plant promoters and methods of use thereof |
| 07/28/2005 | WO2005032469A3 METHODS FOR REGULATING BUD-HYPHA TRANSITION AND cAMP LEVELS IN CANDIDA ALBICANS |
| 07/28/2005 | WO2005026337A3 Adenoviral vector for infecting cells deficient in a car receptor |
| 07/28/2005 | WO2005019252A8 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 07/28/2005 | WO2005018552A3 Heparin binding proteins: sensors for heparin detection |
| 07/28/2005 | WO2005017163A3 Phenotypic knockout of cell-surface proteins |
| 07/28/2005 | WO2005017102A3 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 07/28/2005 | WO2005014650A3 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 07/28/2005 | WO2005013682A3 Animal model for the analysis of tumor metastasis |
| 07/28/2005 | WO2005012339A3 Immunogenic protein and uses thereof |
| 07/28/2005 | WO2005009366A3 Restoring vascular function |
| 07/28/2005 | WO2004111268A3 Mutations in the slc40a1 gene associated to impaired iron homeostasis |
| 07/28/2005 | WO2004069870B1 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 07/28/2005 | WO2004050900A3 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 07/28/2005 | WO2004031206A8 Products for regulating the degradation of collagen and methods for indentifying same |
| 07/28/2005 | WO2004001060A3 Identification and regulation of a g-protein coupled receptor, rai-3 |
| 07/28/2005 | WO2003103606A3 Methods and compositions for treating and diagnosing diabetes |
| 07/28/2005 | WO2003094088A8 Mouse olfactory receptor gene superfamily specification |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | WO2003027249A3 High-protein-phenotype-associated plant genes |
| 07/28/2005 | WO2002097036A3 Compositions and methods for adipose abundant protein |
| 07/28/2005 | WO2002081497A3 αξβ3 INTEGRIN-BINDING POLYPEPTIDE MONOBODIES AND THEIR USE |
| 07/28/2005 | WO2002070656A3 Dna encoding human cid1 |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050166290 Expression cassettes and methods for delivery of animal vaccines |
| 07/28/2005 | US20050166287 Mag1 nucleic acid molecules and their uses |
| 07/28/2005 | US20050166286 Use of naturally occurring antimicrobial polypeptides isolated from insects induced with plant pathogens; genetic engineering; fungicide |
| 07/28/2005 | US20050166284 Plant activation of insect toxin |
| 07/28/2005 | US20050166276 Light-repressible promoters |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050166270 Bioassay for identifying modulators of the biological activity of a serotonin reuptake transporter and for identifying if such a modulator has a secondary target; contacting a Caenorhabditis elegans nematode lacking a wild type polypeptide and expressing a mutated C. elegans polypeptide |
| 07/28/2005 | US20050165889 System and method for monitoring and analyzing internet traffic |
| 07/28/2005 | US20050165224 Inhibition of penicillin resistance in s. pneumoniae |
| 07/28/2005 | US20050165221 Methods for producing factor VIII proteins |
| 07/28/2005 | US20050165219 Related to the thymic stromal cotransporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity |
| 07/28/2005 | US20050165218 Retinoic acid protein crystal for identifying modulators of cholesterol, nervous system, cell proliferative, inflammatory, skin and dietic disorders; antitumor, antiinflammatory, anticholesterol agents |
| 07/28/2005 | US20050165216 Process and systems for recovery of peptides |
| 07/28/2005 | US20050165215 Peptide synthesis and deprotection using a cosolvent |
| 07/28/2005 | US20050164984 Chondroitin synthase gene and methods of making and using same |
| 07/28/2005 | US20050164974 Ligand is covalently linked to polyoxyethylene glycol having specific binding affinity for vascular endothelial growth factor; SELEX method; improved pharmacokinetics |
| 07/28/2005 | US20050164969 Method of extending life span |
| 07/28/2005 | US20050164965 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 07/28/2005 | US20050164962 Method for the identification of tissue-specific regulatory sequences |
| 07/28/2005 | US20050164948 Methods of treatment with prosaposin-derived peptides |
| 07/28/2005 | US20050164946 Mammalian somatoliberin for use in the prevention and treatment of anemia, cachexia, aberrant wound and bone healing, osteoporosis and obesity; veterinary medicine |
| 07/28/2005 | US20050164944 Promoting osteodifferentiation by coating a substrate with a solution of a synthetic peptide having -Ile-Ala residues folded in a beta-bend and mimics cell binding by collagen, incorporation into a biocompatible gel, exposure to cells; hard and soft tissue repair |
| 07/28/2005 | US20050164943 Purified polypeptide consisting of asn-cys-glu-his-phe-val-thr-tyr-cys-arg-tyr-gly (NCEHFVTYCRYG) amino acid sequence; may be part of a fusion protein or conjugated to an agent that increases potency and/or specificity; anticarcinogenic agents; melanomas |
| 07/28/2005 | US20050164941 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens |
| 07/28/2005 | US20050164940 Fus6 family antimicrobial polypeptides and their uses |
| 07/28/2005 | US20050164939 Nucleotide sequences coding polypeptide associated with the generation of disease resistant plants |
| 07/28/2005 | US20050164937 Growth factor homolog zvegf4 |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164935 Therapeutic chemokine receptor antagonists |
| 07/28/2005 | US20050164934 Novel genes associated with the maintenance of differentiation of smooth muscle cells |
| 07/28/2005 | US20050164933 Method of reducing injury to mammalian cells |
| 07/28/2005 | US20050164931 contains 118 amino acids; glycoproteins; immunomodulatory activity; can activate RAW 264.7 macrophage and mouse spleen cell, enhance the production of TNF-alpha and nitric oxide by RAW 264.7 macrophages; induce cell proliferation and IFN-gamma secretion by mouse splenocytes |
| 07/28/2005 | US20050164930 Multimeric protein with linker having sequence ProValSerGlyProArg; [Gly2]hGLP-2 is produced from a multimeric precursor; genetic engineering and expression; biodrugs |
| 07/28/2005 | US20050164929 Methods of preventing and treating inflammatory bowel disease |
| 07/28/2005 | US20050164928 Kallikrein-inhibitor therapies |
| 07/28/2005 | US20050164926 Novel recombinant anticoagulant proteins |
| 07/28/2005 | US20050164925 Treatment of gastroparesis |
| 07/28/2005 | US20050164922 Octapeptides, cyclic peptides; treating Cushings Syndrome, gonadotropinoma, hyperparathyroidism, Paget's disease, irritable bowel syndrome, pancreatitis, Crohn's Disease; inhibiting the secretion of growth hormone, insulin; imaging cells |
| 07/28/2005 | US20050164918 Protein has N terminal hairpin domain and subsequent four kringle domains; hepatocyte growth factor antagonists; angiogenesis inhibitors; deletion or substitution mutants; antitumor and antimetastatic biodrugs |
| 07/28/2005 | US20050164917 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2005 | US20050164914 erectile dysfunction, and female sexual dysfunction; metallopeptide contains aromatic amino acid side chain moieties and does not bind any melanocortin receptor; combination therapy with phosphodiesterase inhibitor or melanocortin receptor MC4-R agonist |
| 07/28/2005 | US20050164912 Alternating and repeating cycles of swelling and shrinking; washing, extraction; peptide is enfuvirtide; precipitation, concentration, recovering |
| 07/28/2005 | US20050164910 Decomposing gelatin or collagen using collegenase; purification by gel filtration; antiallergens |
| 07/28/2005 | US20050164906 Inhibitors of the Mitogen Activated Protein Kinases (MAPKs) pathway activated by Ras/Raf complex using GILZ (glucocorticoid-Induced Leucine Zipper) protein related compounds as inhibitors of Raf/Ras-mediated signal transduction; anticarcinogenic agents |
| 07/28/2005 | US20050164408 Solid phase isolation of proteins, nucleic acids and other macromolecules |
| 07/28/2005 | US20050164392 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells |
| 07/28/2005 | US20050164386 Immortalized embryonic stem cells comprising adenoviral early genes for use as bioreactors in the production of proteins that benefit from post-translational or peri-translational modifications |
| 07/28/2005 | US20050164379 Stable cell lines expressing HERG1a and HERG1b |
| 07/28/2005 | US20050164370 Transformed cell co-expressing cytokinin receptor and cytokinin biosynthesis enzyme |
| 07/28/2005 | US20050164369 Expression vector comprising heat shock and phosphoenolpyruvate carboxykinase regulatory sequences for use as tool in enhancing exogenous gene expression |
| 07/28/2005 | US20050164368 Transgenic, grampositive bacteria comprising expression vector coding viricidal agent for use in treatment and prevention of gastrointestinal disorders in infants |
| 07/28/2005 | US20050164363 Acetolactate synthase mixture for identifying modulators of bacterial infection; bactericides; microbiocides |
| 07/28/2005 | US20050164362 Novel purified polypeptides from pseudomonas aeruginosa |
| 07/28/2005 | US20050164361 Using self-structuring beta amyloid sequences as tool in identifying treatments for alzheimers and neurodegenerative diseases |
| 07/28/2005 | US20050164356 Process for the preparation of L-amino acids using strains of the enterobacteriaceae family |
| 07/28/2005 | US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection |
| 07/28/2005 | US20050164349 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA Polymerase and thereby prevent the assembly of a poised transcriptional complex |
| 07/28/2005 | US20050164348 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 07/28/2005 | US20050164345 Transgenic prokaryotic cell for use as bioreactor in propagation of prolyl 4-hydroxylase |
| 07/28/2005 | US20050164344 Metabotropic glutamate receptor regulator for use in identifying modulator of channel-mediated intracellular calcium mobilization and treatment of nervous system disorders |
| 07/28/2005 | US20050164343 Novel compounds |
| 07/28/2005 | US20050164337 Using metal affinity chromatography to isolate beta -conglycinin-enriched soluble protein fraction for use in treatment of hyperlipidemias; anticholesterol agents |
| 07/28/2005 | US20050164310 Using voltage sensitive dyes to identifying modulators of G-protein sensory signaling; immunoassay; customizing taste of foods and/or medicines |
| 07/28/2005 | US20050164303 Specific-C-peptide assay method |
| 07/28/2005 | US20050164301 Low density lipoprotein/epidermal growth factor conjugate; directed protein evolution |
| 07/28/2005 | US20050164295 allowing a phosphorylated Smad protein or protein complex to interact with a target protein peptide in the presence of a test compound, analyzing the binding of phosphorylated Smad protein complex or protein and the target protein or peptide |
| 07/28/2005 | US20050164291 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/28/2005 | US20050164288 Using g protein coupled receptor to identifying modulator for use in treatment and prevention of pain; antinociceptive agents |
| 07/28/2005 | US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders |
| 07/28/2005 | US20050164280 Twisted gastrulation (TSG) polypeptide for designing drugs to regulate hematopoietic stem cell generation; treating blood disorders |
| 07/28/2005 | US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same |
| 07/28/2005 | US20050164278 Breast cancer specific genes (BSG) and diagnosing/preventing cell proliferative disorders; immunotherapy; paramagnetic imaging |
| 07/28/2005 | US20050164277 Novel human hemicentin proteins and polynucleotides encoding the same |
| 07/28/2005 | US20050164266 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/28/2005 | US20050164265 Single stranded DNA binding proteins from archaea and uses therefor |